Guardion Health Sciences Announces Pricing of Aggregate $4.75 Million Institutional Private Placement of Series C and Series D Redeemable Preferred Stock PressReach · Nov 30, 2022
Tonix Pharmaceuticals Announced Data from its Fully Human anti-SARS-CoV-2 Monoclonal Antibody Platform in an Oral Presentation at the World Antiviral Congress PressReach · Nov 30, 2022
WuXi AppTec Receives 2022 Global Contract Research, Development and Manufacturing Organization Company of the Year Award from Frost & Sullivan PressReach · Nov 30, 2022
Eleven Experts from Leading Medical Institutions and Eight Experts from Eisai Publish Full Results of Lecanemab Phase 3 Confirmatory Clarity Ad Study for Early Alzheimer's Disease in the New England Journal of Medicine PressReach · Nov 30, 2022
Eisai Announces Approval of Partial Change to Label for Dosage and Administration of Aricept for Treatment of Dementia with Lewy Bodies PressReach · Nov 29, 2022
Compugen to Participate in the JMP Securities Hematology and Oncology Summit PressReach · Nov 29, 2022
GeoVax to Present at the World Vaccine & Immunotherapy Congress West Coast 2022 PressReach · Nov 29, 2022
Philips launches new compact ultrasound system at RSNA 2022, allowing first-time-right diagnosis for more patients PressReach · Nov 29, 2022
Syncona Limited Portfolio Company Extends Tender Offer to Acquire Applied Genetic Technologies Corporation PressReach · Nov 29, 2022
Context Therapeutics® Nominates CTIM-76 Bispecific Antibody Candidate to Develop Treatment for Claudin 6-Positive Solid Tumors PressReach · Nov 29, 2022